As neuroimaging research continues to push the boundaries on early Alzheimer’s disease detection, some experts are finding the patient knows best.

Today, the U.S. Centers for Disease Control and Prevention (CDC) and the Alzheimer's Association® unveiled The Healthy Brain Initiative: The Public Health Road Map for State and National Partnerships, 2013-2018 at the 2013 Alzheimer's Association International Conference (AAIC® 2013) in Boston.

Researchers at McCusker Alzheimer's Research Foundation in Perth, Australia, have begun a study to evaluate the effectiveness of an eye test for Alzheimer’s disease, according to News.com.au.

GE Healthcare today announced a research collaboration agreement with Eisai Inc. for use of the GE Healthcare investigational PET amyloid imaging agent, [18F]flutemetamol, to help select patients for a phase I clinical trial being conducted by Eisai.

Specialists with Connecticut-based Oxford Performance Materials have used 3D printing technology to replace three-quarters of a man’s injured skull, according to the New York Daily News.

Chronic traumatic encephalopathy (CTE) has been blamed for a number of high profile suicides among National Football League players, but some are wondering if the degenerative brain disease could have been a factor in the Boston Marathon bombings.

A new genetically engineered lab rat that has the full array of brain changes associated with Alzheimer's disease supports the idea that increases in a molecule called beta-amyloid in the brain causes the disease, according to a study, published in the Journal of Neuroscience.

Scientists at the ATR Computation Neuroscience Laboratories in Kyoto, Japan, have found a way to predict what a person is dreaming about based on fMRI scans of dreamers.